MedPath

An Observational Study of Treatment for Unresectable Masaoka Stage III/IV and Recurrent Thymoma in Real World

Not Applicable
Conditions
nresectable Masaoka III/IV stage and recurrent thymoma
Registration Number
JPRN-UMIN000048181
Lead Sponsor
Juntendo University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
207
Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath